Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Science37 Inc

Neither a doctor nor a teaching hospital

Research payments

$9,701,202

155 payments

Through program year 2025, Science37 Inc is reported as receiving $9,701,202 in research payments, across 155 payments.

By program year

5 rows
Year Kind Amount Payments
2025 Research $1,273,470 40
2024 Research $1,866,289 52
2023 Research $1,430,103 27
2022 Research $2,724,877 28
2021 Research $2,406,464 8

Breakdown

Who paid Research payments · program years 2021–2025
  1. GlaxoSmithKline, LLC. $9,701,202 155 payments
Studies the money was for Research payments · program years 2021–2025
  1. A Two-Part, Randomized, Placebo Controlled, Double Blind, Multicenter, $7,341,363 84 payments
  2. Linerixibat (Gsk2330672) Ileal Bile Acid Transport (Ibat) Inhibitor (O $2,330,522 70 payments
  3. Phase Iib Multi-Center, Randomised, Partial-Blind Parallel Cohort Stud $29,317 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record